Skip to main content
Figure 2 | Veterinary Research

Figure 2

From: An equine iPSC-based phenotypic screening platform identifies pro- and anti-viral molecules against West Nile virus

Figure 2

Permissivity of equine neural progenitor cells and neurons to WNV. AD Equine NPCs and equine neural cells differentiated for 14 days from eNPCs (eDNCs) were infected with WNVNY99 at MOI 10–1. A Immunofluorescence labeling with antibodies against WNV-E3 (red) and βIII-Tubulin (green). B Immunofluorescence labeling with WNV-E3 antibody (red) shows virus spreading in eNPCs. Cells were stained with DAPI (blue). C Viral RNA from supernatant was analyzed by RT-qPCR. D Virus in supernatant was titrated by end-point dilution (TCID50). E, F Equine NPC were infected at MOI from 10–4 to 1 and enumerated automatically based on fluorescent staining using an OPERA instrument. Enumeration of E the percentage of WNV-infected eNPCs (immunostaining with WNV-E3 antibody) and F total eNPCs number (DAPI staining). Normalization was to non-infected eNPCs at 24 h (F). Results are pooled from 3 independent experiments performed in duplicate (C, D) or representative of 3 independent experiments performed in 6 replicates (E, F). Data are expressed as the mean ± SD. Comparison between cells infected for 48/72 h and cells infected for 24 h (CE) and comparison between infected cells (at MOI from 10–4 to 1) and non-infected cells at the same time post-infection (F) were performed with a two-tailed unpaired Mann–Whitney test with p-values significant when *p < 0.05, **p < 0.01.

Back to article page